Drugs that contain Levothyroxine Sodium

1. Drug name - LEVOLET

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10231931 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same Mar, 2038

(15 years from now)

US10406108 GENUS LIFESCIENCES Thyroid hormone oral dosage forms and methods of using the same Mar, 2038

(15 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription

2. Drug name - LEVOTHYROXINE SODIUM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9168239 FRESENIUS KABI USA Levothyroxine formulations Aug, 2032

(9 years from now)

US9168238 FRESENIUS KABI USA Levothyroxine formulations Aug, 2032

(9 years from now)

US9006289 FRESENIUS KABI USA Levothyroxine formulations Oct, 2032

(10 years from now)

US10398669 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

US9782376 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

US11135190 FRESENIUS KABI USA Levothyroxine liquid formulations Dec, 2036

(14 years from now)

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
100MCG/VIAL POWDER;INTRAVENOUS Prescription
200MCG/VIAL POWDER;INTRAVENOUS Prescription
500MCG/VIAL POWDER;INTRAVENOUS Prescription

3. Drug name - LEVOTHYROXINE SODIUM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11154498 CUSTOPHARM INC Stabilized liquid formulation of levothyroxine Jul, 2036

(13 years from now)

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
100MCG/ML SOLUTION;INTRAVENOUS Prescription

4. Drug name - LEVOXYL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7101569 KING PHARMS Methods of administering levothyroxine pharmaceutical compositions Oct, 2023

(1 year, 2 days from now)

Treatment: Method of use of administering levothyroxine

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium TABLET;ORAL Prescription
0.3MG TABLET;ORAL Discontinued

5. Drug name - THYQUIDITY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050307 VISTAPHARM Method for the preparation of a levothyroxine solution Aug, 2031

(8 years from now)

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
100MCG/5ML SOLUTION;ORAL Prescription

6. Drug name - TIROSINT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7723390 INSTITUT BIOCHIMIQUE Pharmaceutical formulations for thyroid hormones Mar, 2024

(1 year, 5 months from now)

US7691411 INSTITUT BIOCHIMIQUE Pharmaceutical formulae for thyroid hormones and procedures for obtaining them Mar, 2024

(1 year, 5 months from now)

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
0.013MG CAPSULE;ORAL Prescription
0.025MG CAPSULE;ORAL Prescription
0.05MG CAPSULE;ORAL Prescription
0.075MG CAPSULE;ORAL Prescription
0.088MG CAPSULE;ORAL Prescription
0.1MG CAPSULE;ORAL Prescription
0.112MG CAPSULE;ORAL Prescription
0.125MG CAPSULE;ORAL Prescription
0.137MG CAPSULE;ORAL Prescription
0.15MG CAPSULE;ORAL Prescription
0.175MG CAPSULE;ORAL Prescription
0.200MG CAPSULE;ORAL Prescription

7. Drug name - TIROSINT-SOL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537538 INSTITUT BIOCHIMIQUE High-stability packaged solutions of T4 thyroid hormone Feb, 2037

(14 years from now)

US11096913 INSTITUT BIOCHIMIQUE High-stability packaged solutions of T4 thyroid hormone Feb, 2037

(14 years from now)

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
13MCG/ML SOLUTION;ORAL Prescription
25MCG/ML SOLUTION;ORAL Prescription
37.5MCG/ML SOLUTION;ORAL Prescription
44MCG/ML SOLUTION;ORAL Prescription
50MCG/ML SOLUTION;ORAL Prescription
62.5MCG/ML SOLUTION;ORAL Prescription
75MCG/ML SOLUTION;ORAL Prescription
88MCG/ML SOLUTION;ORAL Prescription
100MCG/ML SOLUTION;ORAL Prescription
112MCG/ML SOLUTION;ORAL Prescription
125MCG/ML SOLUTION;ORAL Prescription
137MCG/ML SOLUTION;ORAL Prescription
150MCG/ML SOLUTION;ORAL Prescription
175MCG/ML SOLUTION;ORAL Prescription
200MCG/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.